Cellestis Overview

  • Founded
  • 2000
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $368M
Latest Deal Amount

Cellestis General Information

Description

Developer of medical diagnostic technologies. The company has developed and commercialized the QuantiFERON technology, a proprietary approach for early disease detection.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Acquirer
Primary Office
  • 28358 Constellation Drive
  • Unit 698
  • Valencia, CA 91355
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellestis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 29-Aug-2011 $368M 00.000 00000 Completed Generating Revenue
3. PIPE 12-Jun-2004 00.000 00.000 Completed Generating Revenue
2. IPO 24-Apr-2001 $4.99M 000.00 Completed Generating Revenue
1. Early Stage VC 01-Jan-2000 Completed Generating Revenue
To view Cellestis’s complete valuation and funding history, request access »

Cellestis Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Mooroolbark Investments Venture Capital Minority 000 0000 000000 0
To view Cellestis’s complete investors history, request access »